Royce & Associates LP Boosts Stock Position in Select Medical Holdings Co. (NYSE:SEM)

Royce & Associates LP raised its stake in shares of Select Medical Holdings Co. (NYSE:SEMFree Report) by 0.6% in the 3rd quarter, Holdings Channel reports. The fund owned 346,675 shares of the health services provider’s stock after acquiring an additional 1,910 shares during the quarter. Royce & Associates LP’s holdings in Select Medical were worth $12,089,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Hexagon Capital Partners LLC raised its stake in shares of Select Medical by 528.7% during the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after buying an additional 645 shares in the last quarter. Transcendent Capital Group LLC purchased a new position in shares of Select Medical during the 2nd quarter worth approximately $35,000. Canada Pension Plan Investment Board purchased a new position in shares of Select Medical during the 2nd quarter worth approximately $39,000. DekaBank Deutsche Girozentrale purchased a new position in shares of Select Medical during the 2nd quarter worth approximately $60,000. Finally, GAMMA Investing LLC raised its stake in shares of Select Medical by 52.8% during the 2nd quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider’s stock worth $70,000 after buying an additional 685 shares in the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Price Performance

Shares of NYSE:SEM opened at $37.45 on Friday. The business’s fifty day moving average price is $34.81 and its two-hundred day moving average price is $34.73. The stock has a market cap of $4.85 billion, a PE ratio of 17.50, a price-to-earnings-growth ratio of 1.95 and a beta of 1.42. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. Select Medical Holdings Co. has a one year low of $22.26 and a one year high of $40.98.

Select Medical (NYSE:SEMGet Free Report) last posted its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. During the same quarter last year, the firm earned $0.46 earnings per share. The business’s revenue was up 5.7% on a year-over-year basis. On average, analysts forecast that Select Medical Holdings Co. will post 2.16 EPS for the current fiscal year.

Select Medical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th will be issued a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 1.34%. The ex-dividend date is Wednesday, November 13th. Select Medical’s dividend payout ratio (DPR) is 23.36%.

Wall Street Analyst Weigh In

SEM has been the subject of a number of analyst reports. Bank of America initiated coverage on Select Medical in a research note on Tuesday, August 20th. They set a “buy” rating and a $42.00 target price for the company. Royal Bank of Canada raised their price objective on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research note on Wednesday. Finally, Benchmark reaffirmed a “buy” rating and issued a $48.00 price objective on shares of Select Medical in a research note on Friday, November 1st. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $40.75.

View Our Latest Analysis on Select Medical

About Select Medical

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEMFree Report).

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.